Biosimilar Newsletter Archive

21. 02.21.18 -- Better Drug Design: Industry And Clinical Perspectives
    2/21/2018
    02/21/18 Biosimilar Development Newsletter
22. 02.15.18 -- The Biosimilar Stakeholders You Should Be Working With
    2/15/2018
    02/15/18 Biosimilar Development Newsletter
23. 02.13.18 -- Better Treatments By Design
    2/13/2018
    02/13/18 Biosimilar Development Newsletter
24. 02.08.18 -- New Biosimilar Focus Areas Unveiled At CBI 2018 Summit
    2/8/2018
    02/08/18 Biosimilar Development Newsletter
25. 02.06.18 -- Top Clinical Supply Questions That Must Be Asked
    2/6/2018
    02/06/18 Biosimilar Development Newsletter
26. 02.01.18 -- Top Challenges 2018 Will Pose For Biosimilars
    2/1/2018
    02/01/18 Biosimilar Development Newsletter
27. 01.30.18 -- Patient-Centric Approach: From Development To Clinical Trials
    1/30/2018
    01/30/18 Biosimilar Development Newsletter
28. 01.25.18 -- Biosimilar Evolutions To Watch For This Year
    1/25/2018
    01/25/18 Biosimilar Development Newsletter
29. 01.23.18 -- Dose Design Techniques That Improve Development
    1/23/2018
    01/23/18 Biosimilar Development Newsletter
30. 01.18.18 -- What U.S. Biosimilar “Traditions” Need To Be Broken In 2018?
    1/18/2018
    01/18/18 Biosimilar Development Newsletter